Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue.

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

Scher, Howard I; Beer, Tomasz M; Higano, Celestia S; Anand, Aseem; Taplin, Mary-Ellen;

The Lancet – Apr 1, 2010

Download PDF

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

Scher, Howard I; Beer, Tomasz M; Higano, Celestia S; Anand, Aseem; Taplin, Mary-Ellen;

The Lancet – Apr 1, 2010

Loading next page...

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher: Unpaywall
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)60172-9
Publisher site: See Article on Publisher Site

There are no references for this article.